Kids With Skin Diseases Face Stigma, Reduced Quality of Life medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
Sanofi Canada is very pleased to announce that Quebec has extended its listing of DUPIXENT® (dupilumab injection) under the Régie de l'assurance maladie du Québec (RAMQ) to include public reimbursement for Canadians aged 12 years and older whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable. The specific criteria for reimbursement are available on the RAMQ website.